title: Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice.
abstract: The major limitation for the application of an autologous in vitro tissue-engineered reconstructed skin (RS) for the treatment of burnt patients is the delayed vascularization of its relatively thick dermal avascular component, which may lead to graft necrosis. We have developed a human endothelialized reconstructed skin (ERS), combining keratinocytes, fibroblasts and endothelial cells (EC) in a collagen sponge. This skin substitute then spontaneously forms a network of capillary-like structures (CLS) in vitro. After transplantation to nude mice, we demonstrated that CLS containing mouse blood were observed underneath the epidermis in the ERS in less than 4 days, a delay comparable to our human skin control. In comparison, a 14-day period was necessary to achieve a similar result with the non-endothelialized RS. Furthermore, no mouse blood vessels were ever observed close to the epidermis before 14 days in the ERS and the RS. We thus concluded that the early vascularization observed in the ERS was most probably the result of inosculation of the CLS network with the host's capillaries, rather than neovascularization, which is a slower process. These results open exciting possibilities for the clinical application of many other tissue-engineered organs requiring a rapid vascularization.
authors.affiliation: Laboratoire d'organogénèse Expérimentale, Centre hospitalier affilié universitaire de Québec, Hôpital du St-Sacrement and Département de chirurgie, Québec, Canada.
authors.forename: Pierre-Luc
authors.initials: PL
authors.lastname: Tremblay
authors.forename: Valérie
authors.initials: V
authors.lastname: Hudon
authors.forename: François
authors.initials: F
authors.lastname: Berthod
authors.forename: Lucie
authors.initials: L
authors.lastname: Germain
authors.forename: François A
authors.initials: FA
authors.lastname: Auger
mesh_terms: D000818:Animals; D002196:Capillaries / Q000378:metabolism / Q000473:pathology*; D002460:Cell Line; D017690:Cell Transplantation; D002478:Cells, Cultured; D048271:Chitosan / Q000737:chemistry; D003094:Collagen / Q000737:chemistry; D042783:Endothelial Cells / Q000166:cytology; D004730:Endothelium, Vascular / Q000166:cytology; D004817:Epidermis / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism; D006025:Glycosaminoglycans / Q000737:chemistry; D006801:Humans; D007150:Immunohistochemistry; D015603:Keratinocytes / Q000166:cytology; D008297:Male; D051379:Mice; D008819:Mice, Nude; D018613:Microscopy, Confocal; D008856:Microscopy, Fluorescence; D008954:Models, Biological; D009336:Necrosis; D018919:Neovascularization, Physiologic; D011108:Polymers / Q000737:chemistry; D012867:Skin / Q000473:pathology; D016038:Skin Transplantation; D013997:Time Factors; D023822:Tissue Engineering / Q000379:methods*; D014471:Umbilical Veins / Q000166:cytology
chemical_list: D006025:Glycosaminoglycans; D011108:Polymers; D003094:Collagen; D048271:Chitosan